(PAEEM) PEA MSCI Emerging Markets - Overview
Etf: Index, ETF, Emerging, Markets, USD
| Risk 5d forecast | |
|---|---|
| Volatility | 15.0% |
| Relative Tail Risk | -0.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 18.35 |
| Character TTM | |
|---|---|
| Beta | 0.200 |
| Beta Downside | 0.417 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.66% |
| CAGR/Max DD | 0.81 |
Description: PAEEM PEA MSCI Emerging Markets January 01, 2026
The Amundi ETF PEA MSCI Emerging Markets UCITS ETF (ticker PAEEM) tracks the Morningstar EM Total Market Index (NR USD), offering French investors a passively-managed exposure to a broad basket of large- and mid-cap equities across 26 emerging-market economies. It is classified under the “Global Emerging Markets Equity” category and is domiciled in France, making it eligible for the French PEA tax-advantaged wrapper.
Key quantitative attributes (as of Q4 2025) include an expense ratio of roughly 0.20 % TER, assets under management of about €3.2 billion, and a dividend yield near 2.1 %. The fund’s top-10 holdings are dominated by Chinese and Taiwanese technology firms (e.g., Tencent, Taiwan Semiconductor) and South Korean manufacturers, reflecting the sector weightings where information-technology (≈ 22 %) and financials (≈ 18 %) drive performance. Macro-level drivers such as China’s post-COVID growth trajectory, global commodity demand, and the stance of US monetary policy remain the primary levers for total-return volatility in this universe.
If you want a deeper, data-rich breakdown of PAEEM’s risk-adjusted performance and scenario analysis, a quick look at ValueRay’s dashboard can save you hours of manual spreadsheet work.
What is the price of PAEEM shares?
Over the past week, the price has changed by +1.48%, over one month by +4.20%, over three months by +7.27% and over the past year by +24.50%.
Is PAEEM a buy, sell or hold?
What are the forecasts/targets for the PAEEM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 33.3 | 7.5% |
PAEEM Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 523.1m EUR (523.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 523.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 523.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.65% (E(523.1m)/V(523.1m) * Re(6.65%) + (debt-free company))
Discount Rate = 6.65% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)